Role of extracellular matrix and its regulators in human airway smooth muscle biology
- 348 Downloads
Altered extracellular matrix (ECM) deposition contributing to airway wall remodeling is an important feature of asthma and chronic obstructive pulmonary disease (COPD). The molecular mechanisms of this process are poorly understood. One of the key pathological features of these diseases is thickening of airway walls. This thickening is largely to the result of airway smooth muscle (ASM) cell hyperplasia and hypertrophy as well as increased deposition of ECM proteins such as collagens, elastin, laminin, and proteoglycans around the smooth muscle. Many growth factors and cytokines, including fibroblast growth factor (FGF)-1, FGF-2, and transforming growth factor (TGF)-α1, that are released from the airway wall have the potential to contribute to airway remodeling, revealed by enhanced ASM proliferation and increased ECM protein deposition. TGF-α1 and FGF-1 stimulate mRNA expression of collagen I and III in ASM cells, suggesting their role in the deposition of extracellular matrix proteins by ASM cells in the airways of patients with chronic lung diseases. Focus is now on the bidirectional relationship between ASM cells and the ECM. In addition to increased synthesis of ECM proteins, ASM cells can be involved in downregulation of matrix metalloproteinases (MMPs) and upregulation of tissue inhibitors of metalloproteinases (TIMPs), thus eventually contributing to the alteration in ECM. In turn, ECM proteins promote the survival, proliferation, cytokine synthesis, migration, and contraction of human airway smooth muscle cells. Thus, the intertwined relationship of ASM and ECM and their response to stimuli such as chronic inflammation in diseases such as asthma and COPD contribute to the remodeling seen in airways of patients with these diseases.
Index EntriesAirway smooth muscle extracellular matrix cytokine growth factor airway remodeling
Unable to display preview. Download preview PDF.
- 15.Spofford, C. M., and Chilian, W. M. (2001) The elastinlaminin receptor functions as a mechanotransducer in vascular smooth muscle. Am. J. Physiol. 280, H1354-H1360.Google Scholar
- 16.Kranenburg, A. R., Willems-Widyastuti, A., Saxena, P. R., Sterk, P. J., de Boer, W. I., and Sharma, H. S. (2002) Enhanced pulmonary expression of extracellular matrix proteins in central airways of COPD patients. Am. J. Respir. Crit. Care Med. 165, A600.Google Scholar
- 19.Panettieri, R. A., Tan, E. M., Ciocca, V., Luttmann, M. A., Leonard, T. B., and Hay, D. W. (1998) Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am. J. Respir. Cell Mol. Biol. 19, 453–461.PubMedGoogle Scholar
- 25.Coutts, A., Chen, G., Stephens, N., et al. (2001) Release of biologically active TGF-α1 from airway smooth muscle cells induces autocrine synthesis of collagen. Am. J. Physiol. 280, L999-L1008.Google Scholar
- 29.Kranenburg, A. R., Willems-Widyastuti, A., Saxena, P. R., Sterk, P. J., de Boer, W. I., and Sharma, H. S. (2003) Fibroblast growth factors differentially induce mRNA expression of collagens and fibronectin and secretion of transforming growth factor-b1 in cultured human airway smooth muscle cells. Am. J. Respir. Crit. Care Med. 167, A690.CrossRefGoogle Scholar
- 30.Pickering, J. G., Ford, C. M., Tang, B., and Chow, L. H. (1997) Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells. Evidence for repressed collagen production and activated degradative capacity. Arterioscler. Thromb. Vasc. Biol. 17, 475–482.PubMedGoogle Scholar
- 37.Ying, S., Meng, Q., Zeibecoglou, K., et al. (1999) Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C−C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. J. Immunol. 163, 6321–6329.PubMedGoogle Scholar
- 39.Moore, P. E., Church, T. L., Chism, D. D., Panettieri, R. A., Jr., and Shore, S. A. (2002) IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am. J. Physiol. 282, L847-L853.Google Scholar
- 47.Ward, J. E., Gould, H., Harris, T., Bonacci, J. V., and Stewart, A. G. (2004) PPAR gamma ligands, 15-deoxy-delta12,14-protaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms. Br. J. Pharmacol. 141, 517–525.PubMedCrossRefGoogle Scholar